Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Chinese University of Hong Kong
This study is a 1-year non-randomized clinical trial. Two groups of patients (delayed usual care and early intensive care) with diagnosis of rheumatoid arthritis (RA) and with symptoms onset of less than 2 years and disease modifying anti-rheumatic drugs (DMARDs) naive will be recruited. Remission is reached if patients fulfill the Boolean criteria.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
For usual care group:
patients with at least 1 tender and swollen joint
duration of symptoms less than 2 years
no previous use of DMARDs
For intensive care group:
patients with at least 1 tender and swollen joint
duration of symptoms less than 2 years
no previous use of DMARDs
patients who fulfill the 2010 ACR/EULAR classification criteria for RA
You may not be if
patients with renal impairment (on dialysis or estimated Glomerular Filtration Rate (eGFR) \<30 mL/min/1.73m\^2)
